Stability of the circadian alteration in lung function in asthma

J Allergy Clin Immunol. 1992 Mar;89(3):703-8. doi: 10.1016/0091-6749(92)90377-e.

Abstract

Although studies on pharmacologic interventions for nocturnal asthma are increasing, information about the long-term stability of circadian spirometric changes or bronchial responsiveness is not known. This study was undertaken to evaluate these variables in 10 patients with asthma measured quarterly during a 1-year period. We have found that the overnight decrease in peak expiratory flow rate measurements is stable (mean range, 13.8% to 16.4%) during the year, as are the quarterly 4 PM (1600-hour) and 4 AM (0400-hour) FEV1 values. The 4 PM provocative concentration of methacholine that produced a 20% fall in FEV1 (PC20) (range of geometric mean, 0.213 to 0.359 mg/ml) and the 4 AM PC20 (range, 0.057 to 0.152 mg/ml) for the group were also relatively stable. Individual variation was higher for the PC20 values than for the FEV1. We concluded that during a 1-year period, without acute respiratory events, (1) the overnight decrement in peak expiratory flow rate and the 4 AM and 4 PM FEV1 values were constant and (2) bronchial responsiveness demonstrated some individual variability, but for the group, it remained stable.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Asthma / drug therapy
  • Asthma / physiopathology*
  • Bronchial Provocation Tests / methods
  • Circadian Rhythm / drug effects
  • Circadian Rhythm / physiology*
  • Forced Expiratory Volume / drug effects
  • Forced Expiratory Volume / physiology
  • Humans
  • Lung / drug effects
  • Lung / physiopathology*
  • Methacholine Chloride
  • Peak Expiratory Flow Rate / drug effects
  • Peak Expiratory Flow Rate / physiology
  • Theophylline / administration & dosage
  • Time Factors

Substances

  • Methacholine Chloride
  • Theophylline